Aveanna Healthcare Holdings Inc Receivables Turnover Ratio (AVAH), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aveanna Healthcare Holdings Inc   (NASDAQ: AVAH)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Aveanna Healthcare Holdings Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Aveanna Healthcare Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 7.91, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the first quarter 2026. Average collection period, for Aveanna Healthcare Holdings Inc 's accounts receivable remained unchanged at 46 days, in the Apr 04 2026 quarter.

If we take a look into Healthcare sector 248 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Apr 04 2026 from 1848 to 1945.

What is Receivable Turnover Ratio?
What is Aveanna Healthcare Holdings Inc Selling?


What is Receivable Turnover Ratio?





AVAH Receivables Turnover Ratio (Apr 04 2026)
I. Quarter
(Jan 03 2026)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
(Mar 29 2025)
I. Quarter
Y / Y Receivable Change 12.84 % 18.16 % 17.85 % 15.87 % 14.48 %
Y / Y Revenue Change 15.86 % 27.43 % 22.18 % 16.75 % 13.98 %
Receivable Turnover Ratio (TTM) 7.91 7.87 7.71 7.63 7.62
AVAH's Total Ranking # 1945 # 1848 # 438 # 969 # 1587
Accounts Receivable average collection period days 46 46 47 48 48
Seq. Receivable Change 6.17 % 0.17 % -1.09 % 7.27 % 11.18 %
Seq. Revenue Change -2.2 % 6.52 % 5.49 % 5.42 % 7.57 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 29
Healthcare Sector # 249
Overall Market # 1945

Receivable Turnover Ratio Statistics
High Average Low
8.53 6.09 0
(Apr 03 2021)   (Jan 01 2022)






Financial Statements
Aveanna Healthcare Holdings Inc 's Accounts Receivable $ 333 Millions Visit AVAH's Balance sheet
Aveanna Healthcare Holdings Inc 's Sales TTM $ 2,522 Millions Visit AVAH's Income Statement
Sources of AVAH's Revenues Visit AVAH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVAH's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVAH's Growth Rates AVAH's Roa AVAH's Inventory Turnover Ratio AVAH's Dividend Comparisons
AVAH's Profitability Ratios AVAH's Roi AVAH's Asset Turnover Ratio AVAH's Dividend Growth
AVAH's Valuation Ratios AVAH's Roe AVAH's Financial Strength Ratios AVAH's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Apr 04 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Apr 04 2026 Receivable at quarter ending Apr 04 2026
Vystar Corporation  20.58 $ 0.048  Millions$ 0.002  Millions
Lifemd Inc   19.91 $ 177.869  Millions$ 8.934  Millions
Longeveron Inc   19.07 $ 1.216  Millions$ 0.064  Millions
Sonida Senior Living Inc   18.82 $ 411.850  Millions$ 21.878  Millions
Nutriband Inc   16.79 $ 1.803  Millions$ 0.107  Millions
Bioadaptives Inc   16.64 $ 0.024  Millions$ 0.001  Millions
Premier Air Charter Holdings Inc   16.33 $ 33.205  Millions$ 2.033  Millions
Bioage Labs Inc   15.90 $ 10.316  Millions$ 0.649  Millions
Escalon Medical Corp   15.15 $ 11.445  Millions$ 0.756  Millions
Nurix Therapeutics Inc   15.11 $ 71.779  Millions$ 4.750  Millions
Rosecliff Acquisition Corp I  15.05 $ 23.433  Millions$ 1.557  Millions
Lexicon Pharmaceuticals Inc   14.91 $ 69.643  Millions$ 4.670  Millions
Qhslab Inc   14.80 $ 2.775  Millions$ 0.188  Millions
Nexgel Inc   14.19 $ 10.382  Millions$ 0.732  Millions
Sutro Biopharma Inc   14.04 $ 99.608  Millions$ 7.095  Millions
Precipio inc   13.93 $ 25.831  Millions$ 1.854  Millions
China Pharma Holdings Inc  13.86 $ 3.992  Millions$ 0.288  Millions
Talkspace Inc   13.67 $ 239.269  Millions$ 17.501  Millions
Marpai Inc  13.59 $ 17.125  Millions$ 1.261  Millions
Amneal Pharmaceuticals Inc   13.56 $ 3,045.530  Millions$ 224.634  Millions
Corcept Therapeutics Inc  13.20 $ 769.096  Millions$ 58.264  Millions
Xoma Royalty Corporation  13.05 $ 48.555  Millions$ 3.720  Millions
Mannkind Corporation  13.00 $ 360.783  Millions$ 27.757  Millions
Lifestance Health Group Inc   12.74 $ 1,494.791  Millions$ 117.296  Millions
Chemed Corporation  12.73 $ 2,540.548  Millions$ 199.626  Millions
Milestone Scientific Inc   12.69 $ 8.337  Millions$ 0.657  Millions
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions
Skinhealth Systems Inc   12.27 $ 295.223  Millions$ 24.052  Millions
Cytokinetics Incorporated  12.16 $ 105.815  Millions$ 8.702  Millions

Date modified: 2026-08-29T17:43:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.